We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$78.8B
AUM Growth
+$7.07B
Cap. Flow
+$2.22B
Cap. Flow %
2.81%
Top 10 Hldgs %
22%
Holding
3,838
New
237
Increased
1,800
Reduced
1,491
Closed
179

Sector Composition

Rank Sector Weight
1 Technology 11.07%
2 Financials 9.56%
3 Healthcare 8.56%
4 Industrials 6.35%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MN
3501
DELISTED
MANNING & NAPIER, INC.
MN
$60K ﹤0.01%
34,450
-6,550
-16% -$11.4K
HD icon
3502
CALL
Home Depot
HD
$350B
$59K ﹤0.01%
62,700
+17,200
+38% +$3.9M
WRK
3503
CALL
DELISTED
WestRock Company
WRK
$59K ﹤0.01%
46,800
+400
+0.9% +$15.6K
ENDP
3504
DELISTED
Endo International plc
ENDP
$58K ﹤0.01%
+12,400
New +$55.3K
GPRO icon
3505
GoPro
GPRO
$121M
$57K ﹤0.01%
13,152
+1,195
+10% +$4.96K
MDWD icon
3506
MediWound
MDWD
$178M
$57K ﹤0.01%
+2,640
New +$54.8K
KL
3507
CALL
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$57K ﹤0.01%
15,700
-600
-4% -$26.6K
SPY icon
3508
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$56K ﹤0.01%
11,200
-65,200
-85% -$20.1M
HEXO
3509
DELISTED
HEXO Corp. Common Shares
HEXO
$56K ﹤0.01%
629
-86
-12% -$11.3K
BLCM
3510
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$56K ﹤0.01%
4,373
+755
+21% +$6.97K
KNDI
3511
Kandi Technologies Group
KNDI
$63.1M
$55K ﹤0.01%
11,700
-200
-2% -$974
CNSL
3512
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$55K ﹤0.01%
14,195
-13,477
-49% -$51.8K
MBII
3513
DELISTED
Marrone Bio Innovations, Inc.
MBII
$54K ﹤0.01%
53,061
+2,277
+4% +$2.76K
NEM icon
3514
CALL
Newmont
NEM
$124B
$53K ﹤0.01%
72,700
+500
+0.7% +$19.5K
PLUG icon
3515
Plug Power
PLUG
$2.94B
$53K ﹤0.01%
16,879
-2,290
-12% -$6.96K
NBRV
3516
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$52K ﹤0.01%
+159
New +$72.9K
INAP
3517
DELISTED
Internap Corporation
INAP
$52K ﹤0.01%
47,582
-107,468
-69% -$188K
B
3518
CALL
Barrick Mining
B
$68.5B
$51K ﹤0.01%
38,100
+2,300
+6% +$39.5K
DWSN icon
3519
Dawson Geophysical
DWSN
$131M
$50K ﹤0.01%
21,000
STON
3520
DELISTED
StoneMor Inc.
STON
$50K ﹤0.01%
34,732
+5,389
+18% +$6.23K
OGI
3521
Organigram Holdings
OGI
$148M
$49K ﹤0.01%
+5,033
New +$59.4K
CTHR
3522
DELISTED
Charles & Colvard Ltd
CTHR
$49K ﹤0.01%
3,461
+1,705
+97% +$24K
LONE
3523
DELISTED
Lonestar Resources US Inc. Class A Common Stock
LONE
$49K ﹤0.01%
18,732
+1,500
+9% +$3.52K
CMP icon
3524
CALL
Compass Minerals
CMP
$1.13B
$48K ﹤0.01%
19,600
-200
-1% -$11.3K
CVX icon
3525
CALL
Chevron
CVX
$382B
$47K ﹤0.01%
88,700
+15,100
+21% +$1.78M

Similar funds

Raymond James & Associates's Q4 2019 Portfolio in Review

As of Q4 2019, Raymond James & Associates held 3,838 positions worth $78.8B, up 9.9% from $71.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Raymond James & Associates's Q4 2019 filing shows 237 new, 1,800 increased, 1,491 reduced and 179 closed positions. Its largest new stake was Direxion Daily S&P 500 Bear 1X ETF: 343,036 shares worth $8.38M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $325M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q4 2019 buy was Direxion Daily S&P 500 Bear 1X ETF: 343,036 shares worth $8.38M.
  • Raymond James & Associates added most to Vanguard High Dividend Yield ETF in Q4 2019, an estimated $672M increase.
  • Raymond James & Associates's biggest Q4 2019 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $325M.
  • Raymond James & Associates fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $45.9M.
  • Raymond James & Associates's ten largest holdings make up 22% of its $78.8B portfolio in Q4 2019.
  • Raymond James & Associates opened 237 new positions and closed 179 in Q4 2019.
  • Raymond James & Associates's portfolio value rose 9.9% quarter-over-quarter to $78.8B.

Based on Raymond James & Associates's 13F filing for Q4 2019, filed 12 Feb 2020.